Viseca, a provider of products and services in the area of cashless payment, from the issue of payment cards to the development of innovative finance management solutions, has secured a comprehensive refin
Tags :Ex-Featured
Gyrus Capital backed DuPont Sustainable Solutions (DSS), a provider of operations management consulting services has acquired Sofies Group, a global sustainability project management and consulting firm with offices in Geneva, Zurich, London and Bangalore. This
Amag Leasing issued a fixed-interest, senior green bond for CHF 175 million with a coupon of 0.175 percent pa and a term of 3.75 years as part of its newly written Green Finance Framework. The Bonds have been
Niederer Kraft Frey has advised Swiss global private banking group Julius Baer on the bond issuance by its parent company, Julius Baer Group, of USD 320 million perpetual non-cumulative and unsecured Additional Tier 1 (AT1) securities with
Exceet Group, a company of the exceet Group, has entered into an agreement with a fund advised by AFINUM Management to sell its portfolio company GS Swiss PCB. The manufacturer of highly miniaturized printed circuit
Blue Horizon, a venture capital firm active in the food industry, is expanding its operations with the addition of its first general counsel, to support its global portfolio of transformative food businesses. Based in Zurich
Bär & Karrer advised Canada Pension Plan Investment Board (CPPIB), a professional investment management organization, as an investor in Sportradar in connection with Sportradar’s initial public offering. Sportradar is a global provider of
Katadyn Group, a Swiss-based specialist in portable water filters and trekking food, has been acquired by a group of entrepreneurs led by Kontivia, a long-term, down-to-earth investment company and
Doetsch Grether, a company specializing in marketing and sales of products in the pharmaceutical, OTC and consumer care sectors, has entered into an agreement with global pharmaceutical company Vifor Pharma for the takeover of two
Helix Acquisition Corp, a Nasdaq-listed special purpose acquisition company and MoonLake Immunotherapeutics, a Swiss based clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases agreed on a business combination. At
